ropinirole has been researched along with cysteine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdin, MZ; Ahmad, FJ; Ali, M; Beg, S; Fatima, S; Mishra, P; Parvez, S; Quadri, SN; Samim, M | 1 |
1 review(s) available for ropinirole and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for ropinirole and cysteine
| Article | Year |
|---|---|
Crafting ɣ-L-Glutamyl-l-Cysteine layered Human Serum Albumin-nanoconstructs for brain targeted delivery of ropinirole to attenuate cerebral ischemia/reperfusion injury via "3A approach".
Topics: Antioxidants; Brain; Brain Ischemia; Cysteine; Dopamine; Humans; Indoles; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mitochondrial Permeability Transition Pore; Neuroprotective Agents; Reperfusion Injury; Serum Albumin, Human | 2022 |